Cited by 379TGF-β signaling in diseasesCancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

The DOI matches its Crossref record; 318 of the 320 references it cites were found in a registry or an index.

Overcoming TGFβ-mediated immune evasion in cancer

Tauriello, Daniele V. F., Sancho, Elena, Batlle, Eduard·2022·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Transforming growth factor-β (TGFβ) signalling controls multiple cell fate decisions during development and tissue homeostasis; hence, dysregulation of this pathway can drive several diseases, including cancer. Here we discuss the influence that TGFβ exerts on the composition and behaviour of different cell populations present in the tumour immune microenvironment, and the context-dependent functions of this cytokine in suppressing or promoting cancer. During homeostasis, TGFβ controls inflammatory responses triggered by exposure to the outside milieu in barrier tissues. Lack of TGFβ exacerbates inflammation, leading to tissue damage and cellular transformation. In contrast, as tumours progress, they leverage TGFβ to drive an unrestrained wound-healing programme in cancer-associated fibroblasts, as well as to suppress the adaptive immune system and the innate immune system. In consonance with this key role in reprogramming the tumour microenvironment, emerging data demonstrate that TGFβ-inhibitory therapies can restore cancer immunity. Indeed, this approach can synergize with other immunotherapies - including immune checkpoint blockade - to unleash robust antitumour immune responses in preclinical cancer models. Despite initial challenges in clinical translation, these findings have sparked the development of multiple therapeutic strategies that inhibit the TGFβ pathway, many of which are currently in clinical evaluation.

Integrity signals

Registry

Crossref · 10.1038/s41568-021-00413-6

Cites

318 of 318 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: FASN-TGF-β1-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cells
Shen, M., Tsai, Y., Zhu, R., Keng, P. C., Chen, Y., Chen, Y., & Lee, S. O. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.12.012 · Cited by 23
Retracted
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3
Chen, W., Jin, W., Hardegen, N. J., Lei, K.-J., Li, L., Marinos, N. J., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,678
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148

Show all 320 references

Sorted by citations

Items 301–379 of 379

HYL001, a new potent TGFβ signaling inhibitor that is efficacious against microsatellite stable CRC metastasis in combination with immune checkpoint therapy in micePreprint
Tauriello, D. V. F., Sancho, E., Byrom, D., Sánchez, C., Salvany, M., Henriques, A. R., Palomo‐Ponce, S., Sevillano, M., Hernando‐Momblona, X., Matarin, J. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.10.593510 · Cited by 1
Self-citation
Anti-activin treatment increases T cell infiltration in breast and pancreatic tumours and promotes survival in a SMAD4-null mouse pancreatic cancer modelPreprint
McCluney, S. J., Park, D., Miller, D. S. J., Mehić, M., Bloxham, R., de Vries, E., Wang, X., Boeing, S., D’Antonio, L., Wieteska, Ł., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.13.659133 · Cited by 1
Eribulin normalizes pancreatic cancer-associated fibroblasts by simulating TGFβ inhibitionPreprint
Luong, T., & Cukierman, E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.25.482033
RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells
Galassi, C., Ruan, Y., Sato, A., Jiménez‐Cortegana, C., Klapp, V., Bloy, N., Guilbaud, E., Petroni, G., Buqué, A., Galluzzi, L., et al. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2022.05.005
A dramatic impairment of the antitumor activity of human Vγ9Vδ2 T cells is induced by TGF-β through significant phenotype, transcriptomic and metabolic changesPreprint
Rafia, C., Loizeau, C., Renoult, O., Harly, C., Pecqueur, C., Joalland, N., & Scotet, E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.22.509026
Pathogenetic significance of transforming growth factor β1 in patients with colorectal cancer
Chetveryakov, A. V., & Львович, Ц. В. (2022) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2022-7-3-17-22
Radiation therapy: An old dog learning new tricks
Sato, A., Kraynak, J., Marciscano, A. E. E., & Galluzzi, L. (2023) · Methods in cell biology · doi:10.1016/s0091-679x(23)00036-5
Bioinformatics Screening for Targeted Gene Expression Design of Long Noncoding RNA in Glioma Cancer
Zhao, J.-B., Sun, Y., Dong, F.-H., Fang, Y.-Y., Ji, F., Liu, H., Zhang, J., & Wei, R. (2023) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2023.3511
Expression profile and prognostic value of the circadian clock in clear cell renal cell carcinomaPreprint
Kong, B., Zhao, C., Wang, X., Liu, P., Zang, J., Ma, J., Wang, L., & Xu, W. (2023) · Research Square · doi:10.21203/rs.3.rs-2763450/v1
Radiation therapy: An old dog learning new tricks
Sato, A., Kraynak, J., Marciscano, A. E. E., & Galluzzi, L. (2023) · Methods in cell biology · doi:10.1016/s0091-679x(23)00166-8
Comprehensive analysis of m6A RNA methylation regulators in esophageal carcinoma
Yang, H., Liu, J., Li, L., Wang, X., & Li, Z. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-910
Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive microenvironment in cervical adenocarcinomaPreprint
Peng, Y., Li, Y., Ao, J., Shen, J., He, X., Tang, D., Chu, C., Liu, C., & Weng, L. (2024) · eLife · doi:10.7554/elife.97335.1
Failed Induction of the TH1 System in TH2 Dominant Patients: The Cancer-Permissive Immune Macroenvironment.
Yanuck, S. F. (2024) · PubMed Central
Aggressive KRAS mutations direct TGF-β response towards partial EMT in patient-derived colorectal cancer tumoroidsPreprint
Mair, T., König, P., Mijović, M., Tran, L., Saldaña, P. M., Malla, C. U. P., Draganić, K., Pfneissl, J., Tiefenbacher, A., Kabiljo, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.25.600620
TGF-β in tumor microenvironment, metabolism, and immunotherapy
Bai, H., & Wan, Y. Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13827-0.00017-2
Integrated multi-omics analysis and experimental investigation of mitochondrial dynamics-related genes: molecular subtypes, immune landscape, and prognostic implications in lung adenocarcinoma
Wu, S., Pan, J., Zeng, L., Pan, Q., Yu, Y., Lin, J., Zhang, J., & Jiang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1585505
Precisely Targeting TGF‐β1 Promoter G‐Quadruplex for Expediting Maturation of Tumor Dendritic Cells to Overcome Immune Evasion
Ma, C., Sun, Y., Yuan, H., Ya, J., Wang, C., Zhao, C., & Qu, X. (2025) · Small Methods · doi:10.1002/smtd.202500650
TGF-β SIGNALING IN HPV-POSITIVE HEAD AND NECK CANCER: FROM EARLY TUMOR SUPPRESSION TO METASTASIS AND RESISTANCE
Thangavelu, L., Gupta, G., Afzal, M., Alnuaimi, G. R. H., Goyal, A., Goyal, K., Rekha, A., Rana, M., Mishra, R., Prasher, P., et al. (2025) · BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY · doi:10.58240/1829006x-2025.21.4-128
TIPE2 regulates LRRC33-Mediated TGF-β1 activation in MDSCs to restrict lung cancer PD-1 blockade immunotherapy
Ibrahim, A., Liang, Z., Li, R., Salisu, M. D., Liu, M., Zhang, G., Wan, X., & Yan, D. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152683
Quantum Medicine and the Immune System
Barassi, G., Proietti, M., Spaggiari, P., & Colombo, A. (2025) · Springer eBooks · doi:10.1007/978-3-032-00773-5_287
Two-pronged immunosuppression by TGFβ supports colorectal cancer metastasis
(2025) · Nature Genetics · doi:10.1038/s41588-025-02379-9
Nanomedicine in cancer diagnosis and treatment
Isaac, I., Swetz, J., & Bhattacharya, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26761-1.00004-1
A Multi‐Faceted Approach to Explore the Role of Inflammatory CAFs, Providing Prognostic Value and Therapeutic Implications in Lung Adenocarcinoma
Zhou, X., Fu, C., Fu, Y. J., Jiao, T., Zhao, C., & Yang, D. (2025) · International Journal of Genomics · doi:10.1155/ijog/6004629
Additional file 2 of Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma
Liang, S., Ji, L., Yu, Z., Cheng, Y., Gao, R., Yan, W., & Zhang, F. (2024) · Figshare · doi:10.6084/m9.figshare.25303139
Additional file 2 of Insights into inflammation and implications for the pathogenesis and long-term outcomes of endometrial cancer: genome-wide surveys and a clinical cohort study
Wang, J., Chen, Z., Lai, Y., Ma, Z., Wang, L., FIORI, P. L., Carru, C., Capobianco, G., & Zhou, L. (2024) · Figshare · doi:10.6084/m9.figshare.26750342
Additional file 1 of Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma
Liang, S., Ji, L., Yu, Z., Cheng, Y., Gao, R., Yan, W., & Zhang, F. (2024) · Figshare · doi:10.6084/m9.figshare.25302998
Additional file 5 of Insights into inflammation and implications for the pathogenesis and long-term outcomes of endometrial cancer: genome-wide surveys and a clinical cohort study
Wang, J., Chen, Z., Lai, Y., Ma, Z., Wang, L., FIORI, P. L., Carru, C., Capobianco, G., & Zhou, L. (2024) · Figshare · doi:10.6084/m9.figshare.26750351
Additional file 3 of Insights into inflammation and implications for the pathogenesis and long-term outcomes of endometrial cancer: genome-wide surveys and a clinical cohort study
Wang, J., Chen, Z., Lai, Y., Ma, Z., Wang, L., FIORI, P. L., Carru, C., Capobianco, G., & Zhou, L. (2024) · Figshare · doi:10.6084/m9.figshare.26750345
Additional file 1 of Insights into inflammation and implications for the pathogenesis and long-term outcomes of endometrial cancer: genome-wide surveys and a clinical cohort study
Wang, J., Chen, Z., Lai, Y., Ma, Z., Wang, L., FIORI, P. L., Carru, C., Capobianco, G., & Zhou, L. (2024) · Figshare · doi:10.6084/m9.figshare.26750339
Additional file 1 of Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer
Mouillet‐Richard, S., Gougèlet, A., Passet, B., Brochard, C., Corre, D. L., Pitasi, C. L., Joubel, C., Sroussi, M., Gallois, C., Lavergne, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25566247
Additional file 4 of Insights into inflammation and implications for the pathogenesis and long-term outcomes of endometrial cancer: genome-wide surveys and a clinical cohort study
Wang, J., Chen, Z., Lai, Y., Ma, Z., Wang, L., FIORI, P. L., Carru, C., Capobianco, G., & Zhou, L. (2024) · Figshare · doi:10.6084/m9.figshare.26750348
Additional file 2 of Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway
Zhang, T., Xia, W., Song, X., Mao, Q., Huang, X., Chen, B., Liang, Y., Wang, H., Chen, Y., Yu, X., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20517240
Additional file 1 of Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway
Zhang, T., Xia, W., Song, X., Mao, Q., Huang, X., Chen, B., Liang, Y., Wang, H., Chen, Y., Yu, X., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20517237
Additional file 3 of Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma
Liang, S., Ji, L., Yu, Z., Cheng, Y., Gao, R., Yan, W., & Zhang, F. (2024) · Figshare · doi:10.6084/m9.figshare.26685870
Harnessing the Tumor Microenvironment for Cancer Immunotherapy
Fru, P., Nweke, E. E., & Augustine, T. N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00767-4_183 · Cited by 1
The role of m6A modification in non-small cell lung cancer: functional insights and impact on therapy resistance
Yang, Y., Shi, Y., Tao, Z., Ma, Y., & Zhao, J. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04150-w
Landscape of Somatic and Age‐Related Pathogenic Structural Variations in Hepatocellular Carcinoma Revealed by Long‐Read Sequencing
Wei, Z. Y., Cao, Y., Liu, H., Liu, M., Zhang, B., Ying, J., Cai, J. Q., Bi, X., Zhao, J., 周健国, et al. (2026) · MedComm · doi:10.1002/mco2.70570
Development and validation of an oxidative phosphorylation based prognostic model revealing tumor progression and immune microenvironment in lung adenocarcinoma
Ma, H., Zeng, S., Xie, C., Gao, C., Jiang, S., Chen, L., Tian, W., & Huang, L. (2026) · Discover Oncology · doi:10.1007/s12672-026-04478-3
Influence des interactions neuro-immunes sur la croissance tumorale et l'immunité anti-tumorale associée
Daher, C. (2022) · theses.fr (ABES) · doi:10.70675/ca94a2d8z361cz4f7bza02bz641efde9da50
Optimisation immunologique et thérapeutique des doublets de chimio-immunothérapie dans le cancer du sein triple négatif
Kalfeist, L. (2024) · theses.fr (ABES) · doi:10.70675/2ffedd1fza339z474ezadb6z7c5852852067
Deciphering endogenous CD8+ T cell interactions using an engineered sortase A system
He, J., Zhang, C., Yu, X., Zhuang, W., Liang, C., Xue, W., Zhang, W., Lei, Y., Nie, W., & Xie, H.-Y. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100454
Epidermal PPARγ Signaling as a Suppressor of Toll-like Receptor-Mediated Inflammation and Fibrosis: Relevance to Cutaneous Squamous Cell Carcinoma
Konger, R. L., & Derr-Yellin, E. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27094136
Decoding molecular programs that define macrophage responses to tumor-derived cuesPreprint
Hast-Sribike, K., Haeuser, L. J., Acedo-Terrades, A., Puig, R. R., Hau, J., Totu, T., Bossart, J., Patterson, A. B., Krymova, E., Ayala‐Nunez, V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.05.730376
Virus-mimetic Gd-Fe nanocarriers co-delivering cisplatin and a TGF-βRI inhibitor induce ferroptosis and sensitize ovarian carcinoma to PD-1 blockade
Ding, R., Lin, H., Wu, Y., Dong, X., Fan, Y., Chen, L., Lan, G., Shi, Y., Wang, M., & Li, E. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.116804
Integrative PANoptosis-focused omics analysis uncovers GSDMC as a candidate biomarker in breast cancer
Hong, J., Wei, Z., Li, M., Gao, X., Wu, Y. N., Wang, X., Wang, X., Zhang, T., & Song, D. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1841350
Regulatory T Cells: A Critical Factor in the Development and Progression of Hepatocellular Carcinoma
沈, 慶. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662315
A narrative review of new strategies for immunotherapy combination treatment in platinum-resistant ovarian cancer: mechanisms, clinical evidence, and future directions
Zhang, L., Ma, X., & Zhao, X. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1792883
Regulatory B-cell states in NSCLC immunotherapy resistance: mechanisms, spatial context and translational implications
Wang, X., Li, X., Zhou, J., Yang, K., Hu, R., & Pan, B. (2026) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-026-04474-0
Superior in-vivo efficacy of integrated tumor neoantigen vaccination with adoptive neoantigen-reactive T-cell therapy in solid tumor
Liang, G., Zhang, B., Chen, D., Chen, Q., 赖丽嫦, Su, Z., 阮清照, & 阮润生 (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102984
Mechanics and engineering models of tissue remodelling during tumour progression
Thiselton, J., & Kim, P. (2026) · npj Biological Physics and Mechanics. · doi:10.1038/s44341-026-00041-x
CD8 + Tissue‐Resident Memory T Cells in Health and Disease
Ai, Y.-H., Xu, T., Lin, S., Xiao, M., Lin, Y.-X., Ma, H. Y., Liu, Y., Wang, Y., Yin, L., Huang, M., et al. (2026) · MedComm · doi:10.1002/mco2.70838
A truncated TNS3 isoform expressed in metastatic triple negative breast cancer stabilizes FAK and promotes lung metastasis
Morinaga, T., Hayama, S., Nakamura, Y., Kawase, K., Ikeda, H., Miyata, S., Mogi, M., Katayama, E., Nakamura, R., & Kawazu, M. (2026) · Oncogene · doi:10.1038/s41388-026-03894-7
Glioblastoma stem cells as carriers of tumour memory: a strategy for personalised immunotherapy using tumour-infiltrating lymphocytes
Bryukhovetskiy, I., Pak, O., & Polevshchikov, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1880908
Breaking immune exclusion in cold tumors via TGF-β pathway inhibition
Zhang, M., Sun, Y., Chen, L., Xue, D., Zhang, D. X., Yi, M., & Dai, Z. (2026) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2026.2709483
Mathematical modeling of T cell exhaustion in the tumor microenvironment
Adeniyi-Aogo, T. E., & Talkington, A. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109091
Rewriting CAR-T cell fate: CRISPR/Cas gene editing for solid tumor therapy
Liu, W., Gu, J., Xie, C., Bing, D., Liu, M., & Zhang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1910092
Quercetin‐zinc coordination polymer coated CaCO 3 nanoparticles potentiate radiotherapy through reprogramming tumor immunosuppression
Wang, C., Ding, H., Hao, Y., An, H., Dong, Z., Chen, M., Zhu, Y., Li, Q., Huang, B., & Feng, L. (2026) · BMEMat · doi:10.1002/bmm2.70112
Connective tissue dysplasias and the TGF-β paradox: a new concept of the H. pylori-independent Correa cascade (review, perspectives) and therapeutic targeting - Part III
Rudoy, A. S. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-240-8-138-148
Molecular gastric carcinogenesis: formation of a protumor microenvironment in heritable connective (dysplasia) tissue disorders - Part II
Rudoy, A. S. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-240-8-128-137
Turning Cold Tumors Into Hot Tumors: Implications for Cancer Therapy
Ge, X., Han, D., Wang, J., Dai, X., Ma, C., & Chen, F. (2026) · MedComm · doi:10.1002/mco2.70882
Cblb Gene Editing in T Cells Sustains Expansion and Immunogenic CAR T Tumor Killing Under Chronic Antigenic Stimulation
Schreiber, D., Peer, S., Lutz‐Nicoladoni, C., Koutník, J., Lang, V., Wille, V., Hölzl, I., Humer, D., Tokic, N., Freimark, D., et al. (2026) · Cells · doi:10.3390/cells15151407
Natural killer cells at the interface of tumor immune escape and immunotherapy resistance in endometrial cancer
Poggi, A., Bruno, V., Spirito, A. D., Mortara, L., & Baci, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1784443
Differential expression of TGF-β1, TGF-β2, and TGF-β3 across WHO grades in meningioma: convergent evidence from mRNA, methylation, miRNA, and protein analysis
Miller, M., Strojny, D., Sobański, D., Staszkiewicz, R., Gogol, P., Kucybała, W., & Grabarek, B. O. (2026) · Journal of Neuro-Oncology · doi:10.1007/s11060-026-05750-w
TWIST2-dependent transcriptional activation of TPI1 mediates TGF-β1–driven fibroblast activation in pulmonary fibrosis
Chen, J., Li, Y., Fu, K., Qiu, H., Cui, Y., Chen, Z., Yang, J., Shao, C., Zeng, W., Zhou, X., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112844
Oncofetal reprogramming and cellular plasticity in colorectal cancer: from mechanisms to clinical translation
Wang, H., Liu, S., Zhang, M., Deng, C., & Han, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1912866
LTBP4 deficiency induces MRC1 + /CD44 + macrophages to drive cancer progression in preclinical colorectal cancer models
Ji, S., Du, S., Miao, G., Yang, X., Wang, H., Li, X., Ma, W., Wei, D., Cao, T., Zhou, M., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aeb2189
miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities
Kordaß, T., Schlösser, A., Czygan, M., Marques, L. V. C., Wartusch, M., Nerenz, E., Muliawan, V. S., Kersting, S., Osen, W., & Eichmüller, S. B. (2026) · BMC Medicine · doi:10.1186/s12916-026-05146-7
A 42‑Gene TGF‑β Pathway Activity Score in Colorectal Cancer Immune, Prognostic, and Immunotherapeutic Landscape
Farooq, M. A., Atiyah, H. L., ahmed, A. H., & A-Rubaye, T. S. (2026) · PAIN JOINTS SPINE · doi:10.1922/pjs.16.4s.2025.684
A recurrent cancer-associated fibroblast/TGF-beta/endothelial barrier direction is associated with immune exclusion and checkpoint resistance in bladder cancer: a public multi-cohort transcriptomic study
Wu, Y., Li, G., Jiang, L., Zhang, C., Fang, H., & Fan, H. (2026) · PLoS ONE · doi:10.1371/journal.pone.0358043
Phosphorylation destabilizes Per3 to promote gallbladder carcinoma
Fan, K., Cheng, X., Wang, C., Xin, Y., Shen, S., Wang, J., Ni, X., Zheng, B., Liu, H., Suo, T., et al. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.115178
CD24-dependent innate immune checkpoint targeting chimera disrupts TGF-β-driven immunosuppression to enhance anti-tumor therapyPreprint
Cui, Z., Lu, Z., Pan, M., Hu, Y., Gao, M., Ma, A., Hong, Y., Zhang, Y., Chen, X., Wang, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.24.754107
Optimizing antibody-dependent cellular phagocytosis for cancer immunotherapy: mechanisms, constraints, and therapeutic strategies
Ju, M., Zhang, M., Ma, S., An, Y., Xiao, S., Xu, J., Li, N., Chen, Y., Wei, M., Wang, H., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.10.003
Circulating and tumor microenvironment immunomarkers associate with immunotherapy efficacy in advanced bladder urothelial carcinoma: an exploratory multicenter study integrating genomic and immunophenotypic profiling
Liu, S., Lu, J., Lyu, Z., 卢正茂, Liu, Y., Zhang, R., Xu, W., Guoping, S., Du, Y., & Huang, L. (2026) · Immunotherapy · doi:10.1080/1750743x.2026.2744059
Influencing the exposome, patient macroenvironment, tumor microenvironment through-line to improve clinical outcomes
Yanuck, S. F., & Alexis, N. E. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1929067
Non-coding RNA networks remodeling metastatic signaling in the lung cancer microenvironment: a focus on TGF-β signaling and its crosstalk with Wnt/β-catenin, HIF, Notch, integrin, and CXCL12/CXCR4 pathways
AlRamadneh, T. N., Rizaev, J., Kadhim, A. A., Jamuna, K. V., Maharana, L., Bainsal, N., Singhal, D., & Polatova, D. S. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101493
Analysis of the Safety and Efficacy of Cryoablation in Patients with Locally Advanced Pancreatic Cancer
Shao, S., Wang, L., Tan, F., Hou, S., Xue, K., Huang, X., Cao, D., Xiong, J., & Tian, B. (2026) · Annals of Surgical Oncology · doi:10.1245/s10434-026-20731-z
Next‐Generation CAR‐T Cell Therapy: From Modular Design to Clinical Expansion
Bai, Y.-S., Qin, J.-T., Dai, Z.-J., Yan, R., Yang, Y., & Wang, W.-G. (2026) · Exploration · doi:10.1002/exp2.70230
CD8+ T Cell Exhaustion and Tumor Immune Checkpoint Blockade: Mechanisms, Heterogeneity, and Combination Intervention Strategies
Liu, G. (2026) · Advances in World Medical Research · doi:10.71204/dkzdp879
Mutation-Associated cGAS-STING Signaling and the Co-evolution of the Tumor Immune Microenvironment in DNA Damage Repair-Deficient Tumors: From Spatial Architecture to Bedside Translation
Jiang, W., Zhang, Z., Li, X., Shi, R., Pan, B., & Yan, H. (2026) · Seminars in Oncology · doi:10.1016/j.seminoncol.2026.152569

Authors: Tauriello, D. V. F., Sancho, E., & Batlle, E.
Affiliations: Radboud University Medical Center (NL)
Institute for Research in Biomedicine (ES)
Institució Catalana de Recerca i Estudis Avançats (ES)
Corresponding author: Tauriello, Daniele V. F.
Batlle, Eduard
ORCID: Tauriello, Daniele V. F.
Sancho, Elena
Batlle, Eduard
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2021-10-20
Volume: 22
Issue: 1
Pages: 25-44
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/s41568-021-00413-6
OpenAlex: W3206061095
Cited by: 377
References: 320
Citations by year: 2026: 65 · 2025: 101 · 2024: 93 · 2023: 61 · 2022: 55 · 2021: 2
FWCI: 5.58
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
Radboud Repository (Radboud University) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords: TGF-beta signaling, tumor immune microenvironment, immune evasion, cancer-associated fibroblasts, innate immune suppression, TGF-beta inhibition, cancer immunotherapy, immune checkpoint blockade
MeSH terms: Humans, Immunotherapy, Neoplasms, Transforming Growth Factor beta, Immune Evasion, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Overcoming TGFβ-mediated immune evasion in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks